Perfusion Assessment in Critical Limb Ischemia: Principles for Understanding and the Development of Evidence and Evaluation of Devices: A Scientific Statement From the American Heart Association
- PMID: 31401843
- PMCID: PMC7372288
- DOI: 10.1161/CIR.0000000000000708
Perfusion Assessment in Critical Limb Ischemia: Principles for Understanding and the Development of Evidence and Evaluation of Devices: A Scientific Statement From the American Heart Association
Abstract
There are >12 million patients with peripheral artery disease in the United States. The most severe form of peripheral artery disease is critical limb ischemia (CLI). The diagnosis and management of CLI is often challenging. Ethnic differences in comorbidities and presentation of CLI exist. Compared with white patients, black and Hispanic patients have higher prevalence rates of diabetes mellitus and chronic renal disease and are more likely to present with gangrene, whereas white patients are more likely to present with ulcers and rest pain. A thorough evaluation of limb perfusion is important in the diagnosis of CLI because it can not only enable timely diagnosis but also reduce unnecessary invasive procedures in patients with adequate blood flow or among those with other causes for ulcers, including venous, neuropathic, or pressure changes. This scientific statement discusses the current tests and technologies for noninvasive assessment of limb perfusion, including the ankle-brachial index, toe-brachial index, and other perfusion technologies. In addition, limitations of the current technologies along with opportunities for improvement, research, and reducing disparities in health care for patients with CLI are discussed.
Keywords: AHA Scientific Statements; ischemia, lower extremity; perfusion imaging; peripheral arterial disease.
Conflict of interest statement
ARTICLE INFORMATION
The devices listed here serve only to illustrate examples of these types of devices. This is not intended to be an endorsement of any commercial product, process, service, or enterprise by the American Heart Association.
The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.
This statement was approved by the American Heart Association Science Advisory and Coordinating Committee on April 25, 2019, and the American Heart Association Executive Committee on June 4, 2019. A copy of the document is available at
The American Heart Association requests that this document be cited as follows: Misra S, Shishehbor MH, Takahashi EA, Aronow HD, Brewster LP, Bunte MC, Kim ESH, Lindner JR, Rich K; on behalf of the American Heart Association Council on Peripheral Vascular Disease; Council on Clinical Cardiology; and Council on Cardiovascular and Stroke Nursing. Perfusion assessment in critical limb ischemia: principles for understanding and the development of evidence and evaluation of devices: a scientific statement from the American Heart Association.
The expert peer review of AHA-commissioned documents (eg, scientific statements, clinical practice guidelines, systematic reviews) is conducted by the AHA Office of Science Operations. For more on AHA statements and guidelines development, visit
Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American Heart Association. Instructions for obtaining permission are located at
Figures
Similar articles
-
Validation of the relationship between ankle-brachial and toe-brachial indices and infragenicular arterial patency in critical limb ischemia.Vasc Med. 2015 Feb;20(1):23-9. doi: 10.1177/1358863X14565372. Epub 2015 Jan 28. Vasc Med. 2015. PMID: 25630991
-
Heterogeneity of Ankle-Brachial Indices in Patients Undergoing Revascularization for Critical Limb Ischemia.JACC Cardiovasc Interv. 2017 Nov 27;10(22):2307-2316. doi: 10.1016/j.jcin.2017.08.026. JACC Cardiovasc Interv. 2017. PMID: 29169498 Free PMC article.
-
Assessment of foot perfusion: Overview of modalities, review of evidence, and identification of evidence gaps.Vasc Med. 2020 Jun;25(3):235-245. doi: 10.1177/1358863X20909433. Epub 2020 May 2. Vasc Med. 2020. PMID: 32362209 Review.
-
Useful predictors for critical limb ischemia in severely ischemic limbs.Int Angiol. 2016 Oct;35(5):460-8. Epub 2015 May 28. Int Angiol. 2016. PMID: 26017762
-
Health Disparities in Peripheral Artery Disease: A Scientific Statement From the American Heart Association.Circulation. 2023 Jul 18;148(3):286-296. doi: 10.1161/CIR.0000000000001153. Epub 2023 Jun 15. Circulation. 2023. PMID: 37317860 Free PMC article. Review.
Cited by
-
Effects of L-Ornithine-L-Aspartate on Angiogenesis and Perfusion in Subacute Hind Limb Ischemia: Preliminary Study.Biomedicines. 2024 Aug 6;12(8):1787. doi: 10.3390/biomedicines12081787. Biomedicines. 2024. PMID: 39200251 Free PMC article.
-
Complex Peripheral Arterial Disease in a Case of Multilevel Lesions Treated With Sequential Angioplasty.Cureus. 2024 May 24;16(5):e60982. doi: 10.7759/cureus.60982. eCollection 2024 May. Cureus. 2024. PMID: 38915963 Free PMC article.
-
Alginate-Encapsulated Mesenchymal Stromal Cells Improve Hind Limb Ischemia in a Translational Swine Model.J Am Heart Assoc. 2024 May 7;13(9):e029880. doi: 10.1161/JAHA.123.029880. Epub 2024 Apr 19. J Am Heart Assoc. 2024. PMID: 38639336 Free PMC article.
-
Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets.Front Immunol. 2024 Mar 15;15:1331609. doi: 10.3389/fimmu.2024.1331609. eCollection 2024. Front Immunol. 2024. PMID: 38558816 Free PMC article. Review.
-
Clinical physiology: the crucial role of MRI in evaluation of peripheral artery disease.Am J Physiol Heart Circ Physiol. 2024 May 1;326(5):H1304-H1323. doi: 10.1152/ajpheart.00533.2023. Epub 2024 Mar 22. Am J Physiol Heart Circ Physiol. 2024. PMID: 38517227 Review.
References
-
- Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RA, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [published correction appears in Circulation. 2017;135:e790]. Circulation. 2017;135:e686–e725. doi: 10.1161/CIR.0000000000000470 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
